Pope Leo XIV, the first American pope, previously criticized Trump-era policies on social media, but now President Trump says he looks forward to meeting him in a historic moment.
MSA Safety has followed the market’s trajectory closely. The stock is down 9.6% to $157.51 per share over the past six months while the S&P 500 has lost 5.8%. This might have investors contemplating their next move.
REV Group currently trades at $35.80 and has been a dream stock for shareholders. It’s returned 605% since May 2020, blowing past the S&P 500’s 92.9% gain. The company has also beaten the index over the past six months as its stock price is up 16.2% thanks to its solid quarterly results.
Although the S&P 500 is down 5.8% over the past six months, EMCOR’s stock price has fallen further to $440.40, losing shareholders 15.4% of their capital. This might have investors contemplating their next move.
e.l.f. Beauty’s stock price has taken a beating over the past six months, shedding 49.4% of its value and falling to $67.87 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.
Since May 2020, the S&P 500 has delivered a total return of 92.9%. But one standout stock has more than doubled the market - over the past five years, Urban Outfitters has surged 198% to $51.10 per share. Its momentum hasn’t stopped as it’s also gained 31.3% in the last six months thanks to its solid quarterly results, beating the S&P by 37%.
What a brutal six months it’s been for Sportsman's Warehouse. The stock has dropped 29.4% and now trades at $1.73, rattling many shareholders. This may have investors wondering how to approach the situation.
Although the S&P 500 is down 5.8% over the past six months, Constellation Brands’s stock price has fallen further to $192.82, losing shareholders 18.4% of their capital. This might have investors contemplating their next move.
Over the past six months, Wiley’s shares (currently trading at $44.86) have posted a disappointing 15.6% loss while the S&P 500 was down 5.8%. This may have investors wondering how to approach the situation.
Over the last six months, IDEX shares have sunk to $184.65, producing a disappointing 19.5% loss - worse than the S&P 500’s 5.8% drop. This might have investors contemplating their next move.
What a brutal six months it’s been for United Therapeutics. The stock has dropped 23.1% and now trades at $308, rattling many shareholders. This might have investors contemplating their next move.
XPO’s stock price has taken a beating over the past six months, shedding 27.8% of its value and falling to $112.06 per share. This might have investors contemplating their next move.
Domo has followed the market’s trajectory closely. The stock is down 9.8% to $8.18 per share over the past six months while the S&P 500 has lost 5.8%. This might have investors contemplating their next move.
Analog Devices trades at $204.41 per share and has moved almost in lockstep with the market over the last six months. The stock has lost 7.3% while the S&P 500 is down 5.8%. This might have investors contemplating their next move.
Buyers just completed their rotation on the 60min. Combine that with (2) clues on the tick charts, and it looks like Bull Traps are where the money is made tomorrow!
According to the latest data, zero-day-to-expiration (0DTE) options hit a record high in volume this week, a sign that "risk appetite is skyrocketing," say market observers.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Zumiez (NASDAQ:ZUMZ) and the rest of the apparel retailer stocks fared in Q4.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at design software stocks, starting with Unity (NYSE:U).
Let’s dig into the relative performance of General Dynamics (NYSE:GD) and its peers as we unravel the now-completed Q1 defense contractors earnings season.
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the internet of things industry, including Trimble (NASDAQ:TRMB) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how research tools & consumables stocks fared in Q1, starting with Sotera Health Company (NASDAQ:SHC).
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at WESCO (NYSE:WCC) and its peers.
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Cintas (NASDAQ:CTAS) and the best and worst performers in the industrial & environmental services industry.
Looking back on gas and liquid handling stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Flowserve (NYSE:FLS) and its peers.
Looking back on electronic components & manufacturing stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Coherent (NYSE:COHR) and its peers.
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the gas and liquid handling industry, including Standex (NYSE:SXI) and its peers.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Dun & Bradstreet (NYSE:DNB) and the rest of the data & business process services stocks fared in Q1.
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the general industrial machinery industry, including Icahn Enterprises (NASDAQ:IEP) and its peers.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at electronic components & manufacturing stocks, starting with Plexus (NASDAQ:PLXS).
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q1, starting with Vertex Pharmaceuticals (NASDAQ:VRTX).
Markets rose today on hopeful sentiment regarding trade deals with U.S. partners, after an agreement with the UK that kept the baseline +10% tariff in place.
The ride-hailing firm would utilize $500 million of this authorization within the next 12 months, with $200 million to be used in the next three months.
The analyst expects a higher probability of correction in the Nifty index and urges caution. Key levels to watch are 24,230 on the downside and 24,300–24,420 on the upside.
Despite the Q1 miss, management reiterated confidence in its long-term “Vision 2030” strategy, highlighting strong Vyvgart uptake in gMG and CIDP and the recent U.S. approval of a self-injection option.
EUR/USD trimmed into the low end on Thursday, shedding a little over two-thirds of one percent from the day’s opening bids after USD bids caught a broad-market boost following the tentative announcement of a pending trade deal between US and UK.
Warner Bros. Discovery is shifting its streaming strategy to focus on fewer, premium franchises while smartly licensing select titles like Scooby-Doo to Netflix to broaden reach and boost growth.
Despite facing potential tariffs on its cannabis imports to Israel, retail sentiment surged, reflecting optimism around the company’s performance and future growth prospects.
Monster Beverage Corp. (NASDAQ: MNST) is bracing for tighter margins in the second quarter as rising aluminum costs and tariff-related premiums begin to squeeze its bottom line.
